Name: Jade Biosciences, Inc. (JBIO) Balance Sheet
Creator: FinSpry

Jade Biosciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Jade Biosciences, Inc. (JBIO) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Current Assets
Cash and Cash Equivalents	69.39	122.44	129.22	167.38
Short-Term Investments	44.87	0.00	0.00	0.00
Cash & Short-Term Investments	69.39	122.44	129.22	167.38
Accounts Receivable	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00
Other Current Assets	0.27	2.21	0.99	0.53
Total Current Assets	69.65	124.23	131.50	174.33
Non-Current Assets
Property, Plant & Equipment (Net)	0.22	0.89	1.25	0.73
Other Non-Current Assets	3.15	2.28	2.56	0.30
Total Non-Current Assets	0.21	3.17	3.81	1.03
Total Assets	72.80	127.42	135.30	175.36
Current Liabilities
Accounts Payable	1.29	2.40	2.58	1.21
Short-Term Debt	0.42	0.00	0.00	0.00
Accrued Liabilities	9.63	0.00	0.00	0.00
Other Current Liabilities	1.08	14.89	4.89	1.16
Total Current Liabilities	12.00	17.64	7.78	2.55
Non-Current Liabilities
Long-Term Debt	107.60	0.26	0.71	0.38
Other Non-Current Liabilities	0.07	0.00	0.00	0.00
Total Non-Current Liabilities	0.07	0.26	0.71	0.38
Total Liabilities	119.60	17.96	8.56	2.95
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00
Retained Earnings	-46.98	-163.19	-88.37	-36.45
Additional Paid-in Capital	0.00	272.64	215.11	208.87
Total Stockholders' Equity	-46.80	109.46	126.74	172.42
Total Liabilities & Equity	80.33	127.42	135.30	175.36